Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Gene therapy/gene editing combo could offer hope for some genetic disorders
Newer Targets
AmorChem Invests in Novel Approach to Target Myc-driven Cancers
Newer Targets
Researchers at Rush University Medical Center Find That Injecting Influenza Vaccines…
Newer Targets
Research Reveals Promising New Avenues for Anemia Treatment
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Hansa Biopharma Announces Long Term Follow-up Data That Demonstrates 2-year Graft…
Approval
Allergan’s Durysta Implant Approved to Treat Glaucoma
Phase III
AstraZeneca Bladder Cancer Treatment Fails to Hit the Mark in Phase…
Approval
Novadoz Pharmaceuticals Increases Presence in the Generic Oncology Market with an…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Financial
CEPI says funding gap of $2 billion could hamper COVID-19 vaccine…
Deals
AcelRx Announces Agreement for an Investigator-Initiated Study of DSUVIA in Patients…
Commercial
Seelos Therapeutics Receives Notice of Allowance for Composition of Matter Patent…
Deals
Announcement of Joint Research Agreement with Nagoya University for Spinal Cord…
Home
Commercial
Financial
Financial
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Financial
CEPI says funding gap of $2 billion could hamper COVID-19 vaccine development
Firstwordpharma News
-
March 6, 2020
Financial
Trevena to Report Fourth Quarter and Full Year 2019 Results on March 12, 2020Company to host conference call on March 12, 2020, at 8:00...
Financial
Geron to Announce Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020
Financial
Aurinia Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Highlights
Financial
Rafael Holdings Reports Second Quarter Fiscal Year 2020 Results
Financial
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) – March...
Biospace News
-
March 5, 2020
0
Financial
BridgeBio Pharma, Inc. Prices Upsized Offering of $475 Million Convertible Senior...
Biospace News
-
March 5, 2020
0
Financial
Kadmon Highlights Recent Progress and Reports Fourth Quarter and Full Year...
Biospace News
-
March 5, 2020
0
Financial
Zogenix Prices Public Offering of Common Stock – March 03, 2020
Biospace News
-
March 4, 2020
0
Financial
The Median Cost of Bringing a Drug to Market is $985...
Biospace News
-
March 4, 2020
0
1
2
3
...
132
Page 1 of 132
- Advertisement -
MOST POPULAR
BioSpecifics Technologies Corp. Reports First Quarter 2019 Financial and Operating Results
May 10, 2019
DNAtrix Presents Positive Results from the Phase 2 CAPTIVE/KEYNOTE-192 Study of...
November 24, 2019
Adamas’ ADS-5102 succeeds in late-stage study for MS patients with walking...
December 17, 2019
Antibe Therapeutics to Present at 2019 Bloom Burton & Co. Healthcare...
April 26, 2019
Load more
HOT NEWS
Financial
Endo International plc Announces an Upsizing of its Cash Tender Offers...
Deals
Coronavirus Stimulates Biopharma and Academia Research Activities and Collaborations
Neurology
Pfizer and Lilly Announce Top-line Results From Phase 3 Study of...
Phase III
DARZALEX (daratumumab) Phase 3 MAIA Study Results, Published in The New...
